R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.

Autor: Arora P; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, M5T 3M7, Canada.; Inka Health, Schwartz Reisman Innovation Campus, University of Toronto, Toronto, Ontario, M5G 0C6, Canada., Ramagopalan SV; Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2025 Jan; Vol. 14 (1), pp. e240212. Date of Electronic Publication: 2024 Nov 27.

Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making.

Autor: Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. Electronic address: Mina.tadrous@utoronto.ca., Aves T; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Fahim C; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada., Riad J; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Mittmann N; Sunnybrook Research Institute, Toronto, Canada; Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada., Prieto-Alhambra D; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands; Medical Informatics Department, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA., Chan K; Sunnybrook Research Institute, Toronto, Canada., Lix LM; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada., Kent S; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, The Netherlands., Dawoud D; Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, UK., Guertin JR; Faculty of Medicine, Department of Social and Preventive Medicine, Université Laval, Quebec City, Quebec, Canada., McDonald JT; Department of Political Science, University of New Brunswick, Canada., Round J; Institute of Health Economics, Edmonton, Alberta, Canada; Faculty of Medicine and Dentistry, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada., Klarenbach S; Faculty of Medicine and Dentistry, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Stanojevic S; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Canada., De Vera MA; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Strumpf E; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada., Platt RW; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada., Husein F; Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada., Lambert L; Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada., Hayes KN; Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2024 Dec; Vol. 176, pp. 111545. Date of Electronic Publication: 2024 Sep 23.

Outcomes of guidelines from health technology assessment organizations in community-based primary care: a systematic mixed studies review.

Autor: Baradaran A; Department of Family Medicine, McGill University, Montréal, QC, Canada., Tolentino R; Department of Family Medicine, McGill University, Montréal, QC, Canada., Grad R; Department of Family Medicine, McGill University, Montréal, QC, Canada., Ganache I; Institut national d'excellence en santé et en services sociaux (INESSS), Montréal, QC, Canada., Gore G; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montréal, QC, Canada., Abbasgholizadeh Rahimi S; Department of Family Medicine, McGill University, Montréal, QC, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.; Mila-Quebec Artificial Intelligence Institute, Montréal, QC, Canada.; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada., Pluye P; Department of Family Medicine, McGill University, Montréal, QC, Canada.

Publikováno v: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2024 Nov 14; Vol. 40 (1), pp. e56. Date of Electronic Publication: 2024 Nov 14.

Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape.

Autor: Refolo P; Department of Healthcare Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Duthie K; John Dossetor Health Ethics Centre, University of Alberta, Edmonton, AB, Canada., Hofmann B; Department of Health Science, Norwegian University of Science and Technology, Gjøvik, Norway., Stanak M; National Institute for Value and Technologies in Healthcare (NIHO), Bratislava, Slovak Republic., Bertelsen N; Health Technology Assessment international (HTAi) Patient & Citizen Involvement, Neil Bertelsen Consulting, Berlin, Germany., Bloemen B; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., Di Bidino R; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Oortwijn W; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., Raimondi C; Department of Healthcare Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Sacchini D; Department of Healthcare Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., van der Wilt GJ; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands., Bond K; Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.

Publikováno v: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2024 Nov 04; Vol. 40 (1), pp. e39. Date of Electronic Publication: 2024 Nov 04.

Multi-indication Evidence Synthesis in Oncology Health Technology Assessment: Meta-analysis Methods and Their Application to a Case Study of Bevacizumab.

Autor: Singh J; Biostatistics Research Group, Department of Population Health Sciences, University of Leicester, Leicester, UK., Anwer S; Centre for Reviews and Dissemination, University of York, York, UK., Palmer S; Centre for Health Economics, University of York, York, UK., Saramago P; Centre for Health Economics, University of York, York, UK., Thomas A; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Dias S; Centre for Reviews and Dissemination, University of York, York, UK., Soares MO; Centre for Health Economics, University of York, York, UK., Bujkiewicz S; Biostatistics Research Group, Department of Population Health Sciences, University of Leicester, Leicester, UK.

Publikováno v: Medical decision making : an international journal of the Society for Medical Decision Making [Med Decis Making] 2025 Jan; Vol. 45 (1), pp. 17-33. Date of Electronic Publication: 2024 Nov 18.